Related Experiment Video
Updated: Jun 22, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Respiratory dysfunctions induced by prenatal nicotine exposure
Marlys Campos1, Eduardo Bravo, Jaime Eugenín
1Laboratory of Neural Systems, Department of Biology, Universidad de Santiago, USACH, Santiago, Chile.
Clinical and Experimental Pharmacology & Physiology
|May 29, 2009
Summary
Maternal smoking during pregnancy is linked to sudden infant death syndrome (SIDS). Prenatal nicotine exposure disrupts infant respiratory control by altering neurotransmitter systems and neural circuits, increasing SIDS risk.
Area of Science:
- Neuroscience
- Developmental Biology
- Public Health
Background:
- Maternal tobacco smoking is a primary risk factor for sudden infant death syndrome (SIDS).
- SIDS victims often exhibit respiratory control abnormalities, including central apnoeas and impaired chemoreflexes.
- Nicotine is implicated as the key factor linking maternal smoking to SIDS.
Purpose of the Study:
- To investigate the mechanisms by which prenatal nicotine exposure affects infant respiratory control.
- To explore the impact of nicotine on neurotransmitter systems and neural circuit remodelling.
- To understand the potential role of these changes in sudden infant death syndrome pathogenesis.
Main Methods:
- Review of existing literature on prenatal nicotine exposure and respiratory control.
- Analysis of in vitro studies examining nicotine's effects on neurotransmitter systems.
- Hypothesizing the impact of neurotransmitter reorganization and neural circuit remodelling on respiratory network function.
Main Results:
- Prenatal nicotine exposure alters infant breathing patterns and diminishes ventilatory chemoreflexes.
- Nicotine exposure impairs central chemosensitivity, shifting cholinergic drive from muscarinic to nicotinic receptors.
- Multiple neurotransmitter systems (serotonergic, noradrenergic, GABAergic, etc.) are affected by prenatal nicotine.
Conclusions:
- Prenatal nicotine exposure reorganizes neurotransmitter systems and remodels neural circuits in the developing infant.
- These neurobiological changes increase the vulnerability of the respiratory network, potentially contributing to SIDS.
- Understanding these mechanisms is crucial for SIDS prevention strategies related to maternal smoking.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:05Breathing
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.